Shekher Bose

[P. K. CHOUDHARY @chy_prabhash]

@pariksaguru
My daughter passes class Xth 2026 exam. She was student of Sri Chaitanya Techno School Sector 43, Gurgaon
School Admin saying that he still not received original copy of marksheet from CBSE Board. Hence unable to provide.
Kindly clarify why delayed? When we get?

[Vikas Maini @VikasSinghMaini]

Residents of Privvy The Address, Sector 93 GGN are facing repeated power cuts every 2–5 min. Being a high-rise, lift ops & life safety are badly affected. Request @DHBVN_Official & concerned SDO to urgently resolve the issue & update. #Gurugram #PowerCut @anilvijminister

[Vikas Maini @VikasSinghMaini]

@aajtak @OfficialGMDA @CMHaryana1
Fact Check | Sector 93, Gurugram: Despite NGT orders & site visit, GMDA has taken no action on illegal greenbelt encroachment by an under-construction mall. 3,000+ families now commute through a choked lane. Green cover is at risk.Why the delay?

[Course5 Life Sciences @Course5_LifeSci]

The #FDA has accepted the NDA filing for #Verona Pharma’s ($VRNA) #ensifentrine for the maintenance treatment of #COPD and assigned a PDUFA target action date of June 26, 2024. https://t.co/S3kMaUdFcT

[Course5 Life Sciences @Course5_LifeSci]

$GSK (#GSK) Q1’23 key #respiratory highlights - #Trelegy global sales: £465 M (+28% CER); #Trelegy #US sales: £327 M (+26% CER). The #Phase 3 readout and regulatory submission of #Nucala in #COPD in 2024. https://t.co/xWuFrq0KfT

[Course5 Life Sciences @Course5_LifeSci]

#FDA has granted accelerated approval to $BIIB Biogen’s Qalsody (#tofersen) for the treatment of SOD1-ALS. #Qalsody is the first approved treatment to target a genetic cause of #ALS. https://t.co/MilA9F3SSk

[Course5 Life Sciences @Course5_LifeSci]

AAN’23: The 75th AAN Annual Meeting will take place from April 22 -27 in Boston, Massachusetts (In-person and online). To all those interested, here is a @Course5_LifeSci curated list of Multiple Sclerosis-focused sessions at this year's AAN conference.
#AAN2023 #AANAM

[Course5 Life Sciences @Course5_LifeSci]

#AACR23: $MRK (#Merck) KEYMAKER-U02 trial in neoadjuvant setting showed benefit of addition of the vibostolimab (anti-TIGIT) to pembrolizumab – better ORR vs pembro, however the CTLA-4 and LAG-3 combinations appear more robust (MPR) – further investigation warranted

[Course5 Life Sciences @Course5_LifeSci]

#AACR23 is just around the corner!
From the multiple data sessions, Course5i selected a few data that will showcase clinical and preclinical results of promising new IO targets and emerging modalities in cancer research. #solidtumors #oncology #immunotherapy #CancerResearch

[United Association of New Gurugram @DevelopNewGgn]

Dear Residents of New Gurugram
Refer to our meeting held with Honourable @DC_Gurugram,
we have prepared a Proposed list of Societies to have separate wards,(3/4 wards) in @MCManesar if anyone is having any concern related to the same please connect with our member -9711985990

[Course5 Life Sciences @Course5_LifeSci]

#AstraZeneca & #Amgen’s #Tezspire has been approved in the US for self-administration in a pre-filled, single-use pen for patients aged 12 years & older with severe #asthma. The approval was based on the results from the PATHFINDER clinical trial program. https://t.co/macG7hHdB3

[Sumit Minni @Sumitminni1]

@cmohry @nikki160878 Pls note the protest done today sir. Pls note, if situation not resolved by MCM and builder, we will hold protest at MCM office and DC office next for our rights.

[Shekher Bose @ShekherBose]

@cmohry @MCManesar @rakeshdaultabad
Absolutely pathetic condition of road and more than 500 families are at mercy of authorites to take appropriate action. Road connectivity is a basic need and right of every citizen, requesting authorities for a swift action

[Virender Sharma @Virende30406842]

@mlkhattar
Condition of the road is very bad.
Sometimes road remains closed whole days when Sometimes dig the road for contacting their sewer pipeline.
Bhagwan Bharose hai sab kuch.
Virender Sharma
President RWA
Spaze Privvy, Sector-93 (Gurugram)

[Course5 Life Sciences @Course5_LifeSci]

The FDA PADAC has voted 16 to 1 that the data support a favourable benefit risk assessment for the use of #AstraZeneca’s #PT027 for the treatment of #asthma in people aged 18 years and older. https://t.co/scq7Y7yCtE

[Course5 Life Sciences @Course5_LifeSci]

Mitsubishi Tanabe Pharma Canada (#MTP-CA) announced that #Health Canada has granted market authorization for #RADICAVA® (Edaravone) Oral Suspension for the treatment of #ALS. https://t.co/RawjEk2Ezq

[Course5 Life Sciences @Course5_LifeSci]

#Lupin signs agreement to acquire 2 inhalation brands, #Brovana and #Xopenex HFA, from #Sunovion for a purchase price of $75 M.
https://t.co/n4O8iCPsvv

[Course5 Life Sciences @Course5_LifeSci]

#Sanofi’s ($Sanofi) #Dupixent late-breaking Phase 3 data presented at #UEG Week 2022 showed significant histological remission of #eosinophilic esophagitis in children 1–11 years old. Regulatory submission in the US is anticipated in 2023. https://t.co/uEghUaTqsw

[Course5 Life Sciences @Course5_LifeSci]

Supernus Pharmaceuticals received FDA's CRL for SPN-830 NDA. The CRL requires additional information & analysis related to infusion device and drug product across several areas including labeling, quality, manufacturing, device performance & risk analysis https://t.co/ERBScFVRfd

[Sue Eswaran @EswaranSuchitra]

#Pharma2022 - All set for #REpharma2022 - so exited for all the learning. Connect with me on the App. @RE_Pharma @Course5_LifeSci #DataScience #datatransformation #Artificial_Intelligence #pharma22 #patientsafety

[Vatsal Mishra @vatsal014]

Has #Daliresp negated the generic competition to some extent because of its 250 mcg version?
Really don't have the data to support it, but it could be one of the factors..drug reported positive sales in the US for Q2'22